(Total Views: 356)
Posted On: 01/06/2020 3:18:38 PM
Post# of 231
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Biotech Showcase(TM) 2020 in San Francisco
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its plans to attend and present at the Biotech Showcase(TM) 2020, to be held at the Hilton San Francisco Union Square in San Francisco from January 13–15, 2020. Genprex’s President and COO, Julien Pham, MD, MPH, will lead its presentation, scheduled for Monday, January 13 at 11:30 a.m. PT (2:30 p.m. ET); Track: Yosemite C (Ballroom Level). In addition, Pham and the company’s CEO, Rodney Varner, will be available for one-on-one investor meetings. “We are delighted that Genprex will be presenting at Biotech Showcase this year,” Sara Demy, CEO of Demy-Colton, said in the news release. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its plans to attend and present at the Biotech Showcase(TM) 2020, to be held at the Hilton San Francisco Union Square in San Francisco from January 13–15, 2020. Genprex’s President and COO, Julien Pham, MD, MPH, will lead its presentation, scheduled for Monday, January 13 at 11:30 a.m. PT (2:30 p.m. ET); Track: Yosemite C (Ballroom Level). In addition, Pham and the company’s CEO, Rodney Varner, will be available for one-on-one investor meetings. “We are delighted that Genprex will be presenting at Biotech Showcase this year,” Sara Demy, CEO of Demy-Colton, said in the news release. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
